Form 8-K - Current report:
SEC Accession No. 0001628908-22-000025
Filing Date
2022-02-23
Accepted
2022-02-23 16:14:23
Documents
15
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evh-20220223.htm   iXBRL 8-K 38793
2 EX-99.1 a4q21exhibit991.htm EX-99.1 685729
7 image0a06.jpg GRAPHIC 110006
  Complete submission text file 0001628908-22-000025.txt   1091195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20220223.xsd EX-101.SCH 2215
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evh-20220223_def.xml EX-101.DEF 15134
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20220223_lab.xml EX-101.LAB 29284
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20220223_pre.xml EX-101.PRE 15730
9 EXTRACTED XBRL INSTANCE DOCUMENT evh-20220223_htm.xml XML 11839
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 22663816
SIC: 8741 Services-Management Services